Copyright: ©Author(s) 2026.
World J Clin Oncol. Nov 24, 2026; 17(11): 127405
Published online Nov 24, 2026. doi: 10.5306/wjco.127405
Published online Nov 24, 2026. doi: 10.5306/wjco.127405
Figure 1 Mutual relationships among the three sex, seniors, and sarcopenia and chemotherapy for colorectal cancer.
Sex and age independently determine tolerability to cancer therapies. Additionally, both may be associated with sarcopenia, which is a well-known determinant of tolerance to and efficacy of treatments. Therefore, sex and age may indirectly affect treatment outcomes through these confounders. Cancer treatments, in turn, may cause sarcopenia due to muscle damage, reduced physical activity, and/or poor nutrition.
Figure 2 Various interventions for combating sarcopenia.
Of the three sex, seniors, and sarcopenia, sarcopenia is the only one that can be modified. There is sufficient evidence to support exercise and nutritional interventions for treating sarcopenia. However, the effectiveness of other methods, such as bacterial transplantation and hormonal drugs, is still being investigated.
- Citation: Nozawa H, Murono K, Emoto S, Ishihara S. Three S’s (sex, seniors, and sarcopenia) matter during chemotherapy for colorectal cancer. World J Clin Oncol 2026; 17(11): 127405
- URL: https://www.wjgnet.com/2218-4333/full/v17/i11/127405.htm
- DOI: https://dx.doi.org/10.5306/wjco.127405